NCT00054249View on ClinicalTrials.gov

T900607 in Treating Patients With Gastroesophageal Junction Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2002

Primary Completion Date

October 31, 2004

Study Completion Date

September 30, 2010

Conditions
Gastric Cancer
Interventions
DRUG

T900607

Trial Locations (1)

44106-1714

Ireland Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University Hospitals Seidman Cancer Center

OTHER

NCT00054249 - T900607 in Treating Patients With Gastroesophageal Junction Cancer | Biotech Hunter | Biotech Hunter